Notice: This company has been marked as potentially delisted and may not be actively trading. Catalyst Biosciences (CBIO) News Today Add Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Biocom California Names the Ninth Annual Life Science Catalyst Award WinnersOctober 29, 2024 | businesswire.comCatalyst Mutual FundsOctober 4, 2024 | morningstar.comCaribou Biosciences: CB-010, chRDNA Technology Continue To Show Promise In Gene EditingSeptember 30, 2024 | seekingalpha.comStrong Buy Recommendation for Cellectar Biosciences on Positive Phase 2b Results and Solid FinancialsAugust 17, 2024 | markets.businessinsider.comCastle Biosciences, Inc. (CSTL) Q2 2024 Earnings Call TranscriptAugust 6, 2024 | seekingalpha.comNeurocrine Biosciences Heads Into A Catalyst-Rich 2024 With Additional UpsideFebruary 10, 2024 | seekingalpha.comBuy Rating Backed by Pivotal Trial Catalyst and Novel Drug Delivery Platform for Cellectar BiosciencesJanuary 5, 2024 | markets.businessinsider.comBiocom California Names the Eighth Annual Life Science Catalyst Award WinnersNovember 1, 2023 | businesswire.comCatalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and Implementation of Name Change and Reverse Stock SplitOctober 30, 2023 | finance.yahoo.comGeneral Catalyst in German VC tie-up as part of European tech pushOctober 23, 2023 | ft.com'Blind Side' author Michael Lewis suggests catalyst behind Michael Oher lawsuit: 'Violence and aggression'October 18, 2023 | foxnews.comIs Catalyst Biosciences (CBIO) Significantly Overvalued?August 23, 2023 | finance.yahoo.comCatalyst Biosciences (CBIO) Earnings Dates & ReportsAugust 22, 2023 | investing.comCBIO - Catalyst Biosciences, Inc.June 9, 2023 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBIO, TA, ASRTApril 28, 2023 | markets.businessinsider.comCatalyst Biosciences, Inc. (NASDAQ:CBIO) insiders placed bullish bets worth US$941k in the last 12 monthsApril 3, 2023 | finance.yahoo.com5 Cheap Healthcare Stocks to Buy in 2023March 31, 2023 | insidermonkey.comRaymond James Sticks to Its Hold Rating for Catalyst Biosciences (CBIO)March 31, 2023 | markets.businessinsider.com12 Cheap Healthcare Stocks to Buy in 2023March 29, 2023 | finance.yahoo.comCATALYST BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Catalyst Biosciences, Inc. - CBIOMarch 9, 2023 | prnewswire.comCatalyst Biosciences Shares Are Rallying: What's Driving The Action?February 28, 2023 | msn.comCatalyst Biosciences Provides Corporate UpdateFebruary 28, 2023 | finance.yahoo.comGC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in HematologyFebruary 27, 2023 | finance.yahoo.comCatalyst/Millburn Hedge Strategy IFebruary 5, 2023 | morningstar.com5 Stocks with the Lowest PE RatioJanuary 19, 2023 | insidermonkey.comSTOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Catalyst Biosciences, Inc. - CBIOJanuary 4, 2023 | prnewswire.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Catalyst Biosciences, Inc. MergerDecember 29, 2022 | wsj.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, BLI, ISO, CBIODecember 29, 2022 | benzinga.comCBIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Catalyst Biosciences, Inc. Is Fair to ShareholdersDecember 28, 2022 | benzinga.comCatalyst Biosciences Third Quarter 2022 Earnings: US$0.15 loss per share (vs US$0.80 loss in 3Q 2021)November 16, 2022 | finance.yahoo.comHow Much Could This Catalyst Boost Shiba Inu in October?October 7, 2022 | fool.comCBIO Catalyst Biosciences, Inc.September 24, 2022 | seekingalpha.comCatalyst Biosciences, Inc. Announces September 21, 2022 as the Ex-Dividend Date for Special Cash Dividend of $1.43 per shareSeptember 1, 2022 | finance.yahoo.comCatalyst Biosciences, Inc. Declares Special Cash Dividend of $1.43 per shareAugust 25, 2022 | finance.yahoo.comBullish insiders at Catalyst Biosciences, Inc. (NASDAQ:CBIO) loaded up on US$1.2m of stock earlier this yearAugust 23, 2022 | nasdaq.comCatalyst Biosciences (NASDAQ:CBIO) investors are sitting on a loss of 71% if they invested three years agoAugust 23, 2022 | finance.yahoo.comCatalyst Biosciences, JDS1 Reach Agreement For Dismissal Of LitigationAugust 19, 2022 | nasdaq.comJDS1, LLC Terminates Proxy Contest at Catalyst's 2022 Annual MeetingAugust 11, 2022 | tmcnet.comJDS1, LLC Terminates Proxy Contest at Catalyst’s 2022 Annual MeetingAugust 11, 2022 | finance.yahoo.comCatalyst Biosciences Announces Withdrawal of JDS1 Nominations to the BoardAugust 10, 2022 | finance.yahoo.comLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Catalyst Stockholders Vote “FOR” All of the Company’s Nominees on the WHITE Proxy CardAugust 3, 2022 | finance.yahoo.comCatalyst Biosciences Announces Support from Largest Single StockholderAugust 1, 2022 | finance.yahoo.comCatalyst Biosciences Publishes New Investor PresentationAugust 1, 2022 | finance.yahoo.comCatalyst Biosciences Inc - Stock NewsJuly 24, 2022 | morningstar.comJDS1, LLC Files Definitive Proxy Statement and Sends Letter to Catalyst StockholdersJuly 22, 2022 | finance.yahoo.comWith millions of dollars at stake, a small biotech and an activist investor clashJuly 19, 2022 | bizjournals.comCatalyst Biosciences Sends Letter to StockholdersJuly 19, 2022 | finance.yahoo.comHas Adicet Bio (ACET) Outpaced Other Medical Stocks This Year?July 14, 2022 | finance.yahoo.comCatalyst Biosciences Says Court Denies Motion For Expedited Proceedings By JDS1July 6, 2022 | nasdaq.comCatalyst Biosciences Comments on Favorable Delaware Court of Chancery RulingJuly 6, 2022 | finance.yahoo.com Get Catalyst Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now CBIO Media Mentions By Week CBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CBIO News Sentiment▼0.000.46▲Average Medical News Sentiment CBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CBIO Articles This Week▼00▲CBIO Articles Average Week Get Catalyst Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CBIO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.